New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach.

Adv Ther · 2020 · PMC7467491 · PMID 32200535

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

almost reached significancep = 0.063so close (0.05 < p ≤ 0.1)

In the group treated with 1,8-cineole, the number of exacerbations was significantly ( p < 0.036) reduced by 38.5%, as were the severity and duration, FEV1 increased by 78 ml in the range of clinical significance and the improvement in SGRQ scores almost reached significance ( p = 0.063).

also in 321 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.